Trichomonas vaginalis infection activates cells through toll-like receptor 4

Clinical Immunology

Volumn 111, Issue 1, 2004, Pages 103-107

  Zariffard, M Reza ^a   Harwani, Sailesh ^a   Novak, Richard M ^b   Graham, Parrie J ^b   Ji, Xin ^a   Spear, Gregory T ^a  

^a RUSH UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Genital tract; Lipopolysaccharide, 2 defensin.; TNF ; Toll like receptor; Trichomonas vaginalis

Indexed keywords

BETA DEFENSIN 2; LIPOPOLYSACCHARIDE; POLYMYXIN B; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; BACTERIAL INFECTION; CELL ACTIVATION; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; GENITAL SYSTEM; HUMAN; INFLAMMATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRICHOMONAS VAGINALIS; VAGINA SECRETION;

ANIMALS; BETA-DEFENSINS; BODILY SECRETIONS; CELL LINE; FEMALE; HUMANS; IRRIGATION; LEUKOCYTES; MEMBRANE GLYCOPROTEINS; MICE; MONOCYTES; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; TUMOR NECROSIS FACTOR-ALPHA; VAGINA;

EID: 1842785757     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2003.12.008     Document Type: Article

References (32)

1. Cates W. Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex. Transm. Dis. 26:1999;S2-S7.
2. Sorvillo F., Smith L., Kerndt P., Ash L. Trichomonas vaginalis, HIV, and African-Americans. Emerg. Infect. Dis. 7:2001;927-932.
3. Schwebke J.R. Update of trichomoniasis. Sex. Transm. Infect. 78:2002;378-379.
4. Fouts A.C., Kraus S.J. Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis. J. Infect. Dis. 141:1980;137-143.
5. Sardana S., Sodhani P.et al. Epidemiologic analysis of Trichomonas vaginalis infection in inflammatory smears. Acta Cytol. 38:1994;693-697.
6. Kiviat N.B., Paavonen J.A.et al. Cytologic manifestations of cervical and vaginal infections. I. Epithelial and inflammatory cellular changes. JAMA. 253:1985;989-996.
7. Levine W.C., Pope V.et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J. Infect. Dis. 177:1998;167-174.
8. Laga M., Manoka A.et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS. 7:1993;95-102.
9. Ghys P.D., Diallo M.O.et al. Genital ulcers associated with human immunodeficiency virus-related immunosuppression in female sex workers in Abidjan, Ivory Coast. J. Infect. Dis. 172:1995;1371-1374.
10. Brenier-Pinchart M.P., Pelloux H., Derouich-Guergour D., Ambroise-Thomas P. Chemokines in host-protozoan-parasite interactions. Trends Parasitol. 17:2001;292-296.
11. Shaio M.F., Lin P.R., Liu J.Y., Yang K.D. Generation of interleukin-8 from human monocytes in response to Trichomonas vaginalis stimulation. Infect. Immun. 63:1995;3864-3870.
12. Draper D., Donohoe W., Mortimer L., Heine R.P. Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor. J. Infect. Dis. 178:1998;815-819.
13. Akira S. Mammalian Toll-like receptors. Curr. Opin. Immunol. 15:2003;238.
14. Lien E., Sellati T.J.et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274:1999;33419-33425.
15. Massari P., Ram S., Macleod H., Wetzler L.M. The role of porins in neisserial pathogenesis and immunity. Trends Microbiol. 11:2003;87-93.
16. Prebeck S., Brade H.et al. The Gram-negative bacterium Chlamydia trachomatis L(2) stimulates tumor necrosis factor secretion by innate immune cells independently of its endotoxin. Microbes Infect. 5:2003;463-470.
17. Amsel R., Totten P.A., Spiegel C.A., Chen K.C., Eschenbach D., Holmes K.K. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74:1983;14-22.
18. Folks T.M., Justement J., Kinter A., Dinarello C.A., Fauci A.S. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science. 238:1987;800-802.
19. Poltorak A., He X.et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085-2088.
20. Biragyn A., Ruffini P.A.et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science. 298:2002;1025-1029.
21. Spear G.T., al-Harthi L.et al. A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1-infected and uninfected women. AIDS. 11:1997;1319-1326.
22. Olinger G.G., Hashemi F.B., Sha B.E., Spear G.T. Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1. AIDS. 13:1999;1905-1912.
23. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 21:2003;335-376.
24. Huttner K.M., Bevins C.L. Antimicrobial peptides as mediators of epithelial host defense. Pediatr. Res. 45:1999;785-794.
25. Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir. Res. 1:2000;141-150.
26. Fichorova R.N., Cronin A.O., Lien E., Anderson D.J., Ingalls R.R. Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. J. Immunol. 168:2002;2424-2432.
27. Demes P., Gombosova A., Valent M., Fabusova H., Janoska A. Fewer Trichomonas vaginalis organisms in vaginas of infected women during menstruation. Genitourin. Med. 64:1988;22-24.
28. Kawasaki K., Akashi S., Shimazu R., Yoshida T., Miyake K., Nishijima M. Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J. Biol. Chem. 275:2000;2251-2254.
29. Hajjar A.M., Ernst R.K., Tsai J.H., Wilson C.B., Miller S.I. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3:2002;354-359.
30. Nogal-Ruiz J.J., Gomez-Barrio A., Escario J.A., Martinez-Fernandez A.R. Modulation by Polypodium leucotomos extract of cytokine patterns in experimental trichomoniasis model. Parasite. 10:2003;73-78.
31. Caterina P., Warton A., Papadimitriou J.M., Ashman R.B. Relationship of the virulence of Trichomonas vaginalis and the major histocompatibility complex in murine trichomonad infection. Parasitol. Res. 82:1996;628-633.
32. Abraham M.C., Desjardins M., Filion L.G., Garber G.E. Inducible immunity to Trichomonas vaginalis in a mouse model of vaginal infection. Infect. Immun. 64:1996;3571-3575.